Rab27A has effects on the invasive and metastatic potentials of breast cancer cells by modulating the secretion of IGF-II, which regulates the expression of p16, VEGF, uPA, cathepsin D, cyclin D1, and MMP-9 [15]. The gene discussed is MMP9; the disease is breast carcinoma.